New Drug Approved for Agitation in Alzheimer’s Patients
A new treatment option for those facing agitation linked to dementia brings hope.
The FDA has approved Auvelity, a medication that can help manage agitation in adults with Alzheimer’s disease. Previously, this drug was mostly used to treat depression, but now it can also help those dealing with agitation, which is often a challenging symptom of dementia. Agitation can include feelings of restlessness, irritability, or anxiety.
This marks a significant development since Auvelity is the first non-antipsychotic medication approved for this purpose. It offers a new tool for families and caregivers dealing with the effects of Alzheimer’s.
Why it matters
This approval gives new hope to millions affected by Alzheimer’s, providing an additional option to manage challenging symptoms. It could improve the quality of life for both patients and their caregivers.
What to keep in mind
While this is a positive step, it's important to understand that Auvelity is just one part of managing Alzheimer’s. As more research is done, we’ll learn more about its long-term effects and best practices.
Joi Frontier Health News shares hopeful, credible health information. It is not medical advice, diagnosis, or treatment — talk with a qualified healthcare professional about your situation. If you are in crisis or thinking about self-harm, contact your local emergency or crisis line.